60 DEGREES PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease)
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) of 82.50 thousand shares for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease · last filed 2024-08-14
- 60 DEGREES PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, number of shares, period increase (decrease) for the quarter ending 2024-06-30 was -907.50K shares.
- 60 DEGREES PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, number of shares, period increase (decrease) for the quarter ending 2024-03-31 was 990.00K shares.
- 60 DEGREES PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, number of shares, period increase (decrease) for fiscal 2023 was 740.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) 12 month |
|---|---|---|---|
| 2024-06-30 | -907.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 82.50K shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 990.00K shares 10-Q · filed 2024-05-15 | ||
| 2023-12-31 | 740.00K shares 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |